期刊文献+

肝硬化患者血管紧张素转化酶测定的临床意义 被引量:1

下载PDF
导出
摘要 血管紧张素转化酶(ACE)广泛分布于人体各组织的血管内皮或上皮细胞,使血管紧张素I(AngI)转化成血管紧张素Ⅱ(AngⅡ),它是调节肾素一血管紧张素一醛固酮系统(RAAS)、缓激肽系统的重要酶,与机体钠水代谢生理调节有密切关系。目前,ACE作为消化系统疾病的一项诊断和治疗指标越来越受重视,在肝硬化患者疾病发生、发展过程中,常伴有肾素一血管紧张素系统(RAS)的异常激活,
机构地区 湖州市中心医院
出处 《中国初级卫生保健》 2011年第9期99-100,共2页 Chinese Primary Health Care
  • 相关文献

参考文献7

二级参考文献36

  • 1涂蓉,张阳德,黄海伟,伍保忠,郑妙琼.正常肝脾容积的CT研究[J].解剖学杂志,2004,27(3):317-318. 被引量:11
  • 2WeiHong-shan LuHan-ming LiDing-guo ZhanYu-tao WangZhi-rong HuangXin.The Regulatory Role of AT 1 Receptor on Activated HSCs in Hepatic Fibrogensis: Effects of RAS Inhibitors on Hepatic Fibrosis Induced by CCI4[J].胃肠病学,2000,5(B08):125-125. 被引量:1
  • 3涂蓉,张阳德,罗建光,郑进方,王海东,夏立平,何东雷.CT肝硬度分级评估肝储备功能的价值研究[J].实用放射学杂志,2005,21(3):256-259. 被引量:9
  • 4涂蓉,曹觉,王山,刘惠,伍保忠,黄海伟.容积测量结合计算机断层成像分级对肝硬化定量诊断的研究[J].中华消化杂志,2005,25(4):245-246. 被引量:7
  • 5Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N,Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T. Pressure-independent effects of angiotensin Ⅱ on hypertensive myocardial fibrosis. Hypertension, 2004, 43:499~503.
  • 6Aizawa T, Ishizaka N, Kurokawa K, Nagai R, Nakajima H, Taguchi J, Ohno M. Different effects of angiotensin Ⅱand catecholamine on renal cell apoptosis and proliferation in rats. Kidney Int, 2001, 59: 645~653.
  • 7Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn M J, Adamson MD, Purdie DM, Powell EE. Angiotensinconverting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology, 2001, 121: 148~155.
  • 8Yoshiji H, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H,Nakatani T, Imazu H, Yanase K, Kuriyama S, Fukui H.Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol, 2002, 37: 22~30.
  • 9陆伦根 茅益民 见:高春芳 陆伦根主编.肝纤维化-诊断[A].见:高春芳,陆伦根主编.纤维化疾病的基础和临床[C].上海:上海科学技出版社,2004.322.
  • 10Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodes J. Angiotensin Ⅱ induces contraction and proliferation of human hepatic stellate cells. Gastroenterology, 2000, 118:1149~1156.

共引文献30

同被引文献14

  • 1S hahidS M , Fatima SN , Mahboob T. Angiotensin convertingenzyme (ACE) gene expression in experimentally induced livercirrhosis in rats. Pak J Pharm Sci,2013,26: 853-857.
  • 2Lee JY , Lee JH , K m DK, et al. C-reactive protein as a prognosticfactor for mortality in pneumonia patients with liver cirrhosis.IIepatogastroenterol,2014,61: 1331-1338.
  • 3Kim SR , Kondo F , Otono Y , et a l Serum amyloid A and C -reactive protein positive nodule in alcoholic liver cirrhosis, hardto make definite diagnosis. Hepatol R es,2014,44: 584-590.
  • 4Lin K H , Wong F L , Wu M S, et al. Serum procalcitonin and Creactiveprotein levels as markers of bacterial infection inpatients with liver cirrhosis: a systematic review and metaanalysis.Diagn Microbll Infec Dis,2014,80:72-78.
  • 5Di Martino V, Coutris C, Cervoni JP, et al. Prognostic value ofC-reactive protein levels in patients with cirrhosis LiverTransplant,2015, 21: 753-760.
  • 6Alempijevit: T ,Sokic-Milutinovic A,ToncevL,etal. Primarybiliary cirrhosis and hepatic sarcoidosis: a case reportVoinosantt Pregl,2 0 1 4,7 1 :83-86.
  • 7Grace JA, Klein S, Herath CB, et al. Activation of the MASreceptor by angiotensin-( 1-7) in the renin-angiotensin systemmediates mesenteric vasodilatation in cirrhosis. Gastroenterology,2013, 1 4 5:874-884.
  • 8FontanaM,BarisonA,BottoN, et al CMR-verified interstitialmyocardial fibrosis as a marker of subclinical cardiac involvementin LMNA mutation carriers. JACC-CardiovascImag,2 0 1 3,6:124-126.
  • 9ZhangW,XuYZ,LiuB, et al Pioglitazone upregulates angiotensinconverting enzyme 2 expression in insulin-sensitive tissues in ratswith high-fat diet-induced nonalcoholic steatohepatitis SciWorld J,2014, 2 0 1 4:603409.
  • 10晏峰,徐伟珍,揭伟霞,任振唤.肝硬化患者血清血管紧张素转化酶和C反应蛋白水平与肝损害程度关系分析[J].浙江医学,2012,34(22):1857-1858. 被引量:2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部